Theravance Biopharma
TBPH
#6351
Rank
NZ$1.61 B
Marketcap
Country
NZ$31.13
Share price
0.00%
Change (1 day)
-1.82%
Change (1 year)

EPS for Theravance Biopharma (TBPH)

EPS in 2026 (TTM): NZ$1.83

According to Theravance Biopharma 's latest financial reports the company's current EPS (TTM) is NZ$1.94. In 2025 the company made an earnings per share (EPS) of NZ$3.82 an increase over its 2024 EPS that were of NZ-$2.10.

EPS history for Theravance Biopharma from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$1.83-52.23%
2025NZ$3.82-281.74%
2024NZ-$2.1018.56%
2023NZ-$1.77-108.41%
2022NZ$21.10-491.19%
2021NZ-$5.39-34.15%
2020NZ-$8.195.16%
2019NZ-$7.796.5%
2018NZ-$7.31-26.61%
2017NZ-$9.9628.24%
2016NZ-$7.77
2014NZ-$13.58

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Corcept Therapeutics
CORT
NZ$2.74 41.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Collegium Pharmaceutical
COLL
NZ$2.23 15.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
NZ$3.31 70.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalent
CTLT
NZ-$11.57-697.17%๐Ÿ‡บ๐Ÿ‡ธ USA